Pathstone Holdings LLC Sells 5,335 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Pathstone Holdings LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the 4th quarter, Holdings Channel reports. The firm owned 148,151 shares of the healthcare conglomerate’s stock after selling 5,335 shares during the quarter. Pathstone Holdings LLC’s holdings in UnitedHealth Group were worth $74,946,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of UNH. Signal Advisors Wealth LLC boosted its stake in UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Waycross Partners LLC grew its stake in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares during the period. Full Sail Capital LLC raised its stake in UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after buying an additional 33 shares during the period. Lmcg Investments LLC grew its stake in UnitedHealth Group by 11.8% in the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after acquiring an additional 4,022 shares during the period. Finally, Seilern Investment Management Ltd acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $153,015,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $311.23 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $282.33 billion, a price-to-earnings ratio of 20.08, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52-week low of $309.10 and a 52-week high of $630.73. The business’s fifty day moving average is $482.53 and its 200 day moving average is $519.28.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the firm posted $6.91 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.70%. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Analyst Ratings Changes

A number of analysts have commented on UNH shares. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Raymond James reaffirmed a “strong-buy” rating and set a $540.00 target price (down previously from $635.00) on shares of UnitedHealth Group in a research report on Monday, April 21st. Barclays dropped their price objective on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a research note on Monday, April 21st. Finally, HSBC restated a “hold” rating and set a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Four investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.